Predictors of premature discontinuation of treatment in multiple disease states

Eric Nantz1 Department of Statistics, Western Michigan University, Kalamazoo, MI, USA

Hong Liu-Seifert2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]

Vladimir Skljarevski2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

Pages 31-43 | Published online: 08 Jan 2009

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ConnorKMTreatment of generalized anxiety disorder: current options and future developments. In: Culpepper L, chair. Effective recognition and treatment of generalized anxiety disorder in primary care [ACADEMIC HIGHLIGHTS]Prim Care Companion J Clin Psychiatry20046354115486599
PubMedGoogle Scholar
SheltonRSteps following attainment of remission: discontinuation of antidepressant therapyPrim Care Companion J Clin Psychiatry2001316817415014601
PubMedGoogle Scholar
LeonACMallinckrodtCHChuang-SteinCArchibaldDGArcherGEChartierKAttrition in randomized controlled clinical trials: methodological issues in psychopharmacologyBiological Psychiatry2007591001100516503329
PubMed Web of Science ®Google Scholar
GoldsteinDJLuYDetkeMJLeeTCIyengarSDuloxetine vs placebo in patients with diabetic neuropathyPain20051161–210911815927394
PubMed Web of Science ®Google Scholar
RichterRWPortenoyRSharmaULamoreauxLBockbraderHKnappLERelief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trialJ Pain20056425326015820913
PubMed Web of Science ®Google Scholar
BackonjaMGlanzmanRLGabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trialsClin Ther20032518110412637113
PubMed Web of Science ®Google Scholar
VinikATuchmanMSafirsteinBLamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studiesPain20071281216917917254713
PubMed Web of Science ®Google Scholar
DograSBeydounSMazzolaJHopwoodMWanYOxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled studyEur J Pain20059554355416139183
PubMed Web of Science ®Google Scholar
PatkarAAMasandPSKrulewiczSA randomized, controlled, trial of controlled release paroxetine in fibromyalgiaAm J Med2007120544845417466657
PubMed Web of Science ®Google Scholar
ArnoldLMGoldenbergDLStanfordSBGabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multi-center trialArthritis Rheum20075641336134417393438
PubMed Web of Science ®Google Scholar
VittonOGendreauMGendreauJKranzlerJRaoSGA double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHum Psychopharmacol200419Suppl 1S27S3515378666
PubMed Web of Science ®Google Scholar
CroffordLJRowbothamMCMeasePJPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trialArthritis Rheum20055241264127315818684
PubMed Web of Science ®Google Scholar
ArnoldLMCroffordLJMartinSAYoungJPSharmaUThe effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgiaPain Med20078863363818028041
PubMed Web of Science ®Google Scholar
RynnMRussellJEricksonJEfficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trialDepress Anxiety200825318218917311303
PubMed Web of Science ®Google Scholar
DavidsonJRBoseAKorotzerAZhengHEscitalopram in the treatment of generalized anxiety disorder: double-blind, placebo-controlled, flexible-dose studyDepress Anxiety200419423424015274172
PubMed Web of Science ®Google Scholar
RickelsDZaninelliRMcCaffertyJBellewKIyengarMSheehanDParoxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled studyAm J Psychiatry2003160474975612668365
PubMed Web of Science ®Google Scholar
PandeACCrockattJGFeltnerDEPregabalin in generalized anxiety disorder: a placebo-controlled trialAm J Psychiatry2003160353354012611835
PubMed Web of Science ®Google Scholar
WardenDTrivediMHWisniewskiSRPredictors of attrition during initial (citalopram) treatment of depression: a STAR*D reportAm J Psychiatry20071641189119717671281
PubMed Web of Science ®Google Scholar
Liu-SeifertHAdamsDHKinonBJDiscontinuation of treatment of schizophrenic patients is driven by poor symptom response: A pooled post hoc analysis of four atypical antipsychotic drugsBMC Med2005232116375765
PubMed Web of Science ®Google Scholar
MullinsCDShayaFTMengFWangJHarrisonDPersistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopramPharmacotherapy20052566066715899727
PubMed Web of Science ®Google Scholar
CollettDModelling Survival Data in Medical Research2nd edLondonChapman and Hall/CRC2003
Google Scholar
BaldwinDSMontgomerySANilRLaderMDiscontinuation Symptoms in depression and anxiety disordersInt J Neuropsychopharmacol200710738416359583
PubMed Web of Science ®Google Scholar
MoserDKDracupKDoeringLVFactors differentiating dropouts from completers in a longitudinal, multicenter clinical trialNurs Res200049210911610768588
PubMed Web of Science ®Google Scholar
KhanASchwartzKReddingNKoltsRLBrownWAPsychiatric diagnosis and clinical trial completion rates: Analysis of the FDA SBA reportsNeuropsychopharmacology2007322422243017314915
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Predictors of premature discontinuation of treatment in multiple disease states

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictors of premature discontinuation of treatment in multiple disease states

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date